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Aims. To investigate the trend of metabolic syndrome and its components in Tehran children and adolescents during a median
followup of 6.6 years. Methods. Data from 1999–2001 (phase I), 2002–2005 (phase II), and 2006–2008 (phase III) of the Tehran,
LipidandGlucoseStudywereanalyzed(n = 5439;age6–18years)forthetrendofmetabolicsyndrome(MetS)anditscomponents.
General estimation equation (GEE) models were used to analyze this correlated data. Results. The crude prevalence of MetS for
boys at baseline was 13.2%, which increased to 16.4% in the third phase. In girls, the prevalence of Mets decreased from 11.8% at
baseline to 6% during followup. The odd ratios (OR) of obesity over the whole study period were raised in both sexes. The OR of
abdominal obesity increased signiﬁcantly in boys, but no change was observed in girls. No signiﬁcant OR was observed in boys,
while OR for MetS was shown to have a decreasing trend in girls during the followup. In the three time points, the ORs of MetS
decreasedsigniﬁcantlyingirlsbutnosigniﬁcantdiﬀerence was observed in boys. Conclusion.Inspiteofincreasingtrendforobesity
in both sexes, the trend of MetS decreased in girls and was relatively stable in boys, in Tehranian children, and adolescents.
1.Introduction
The metabolic syndrome (MetS) is deﬁned as a clustering
of metabolic risk factors including central obesity, hyper-
glycemia, dyslipidemia, and hypertension [1]. In recent
decades, obesity and metabolic risk factors among children
and adolescents have been much focused on several studies
showing that increasing obesity and MetS in this population
is associated with a number of adverse consequences in
adulthood including type 2 diabetes mellitus and coronary
heart disease, most likely due to overproduction of inﬂam-
matory mediators and insulin resistance [2–4].
While current estimates indicate a 2% to 9% prevalence
for MetS in US adolescents [5], 14.1% of Iranian children
have MetS based on ATP III criteria resulting from the
increasing prevalence of overweight and abdominal obesity
among Iranian children and adolescents [6, 7]. Previous
studies also demonstrated higher triglyceride and lower
HDL-C levels in Iranian adolescents compared to their
American counterparts [8, 9]. This increased prevalence
would necessitate the need for identifying the time trend
of Mets and its components in our population. Although
the prevalence and associated risk factors of MetS have been
widelystudiedinrecentdecades[10–12],muchlessisknown
in regard to changes in risk factor status over a longer period
of time during childhood and adolescence, particularly in
developing countries like Iran.
A few studies have evaluated the tracking of MetS and
its components altogether [13–17] and most of them have
provided data in support of a stability of MetS and its
components in their populations [13, 14, 16]. Other studies
have demonstrated an increasing trend in MetS [17] and its
individualcomponents[18–21].Inarecentstudywhichused
three independent sets of cross-sectional data with limited2 Cholesterol
sample size in Tehranian adolescents, aged 10–19 years,
reported an increasing trend for obesity, abdominal obesity
[22]. Given the above-mentioned limitations in this study,
we aimed to examine the trend of MetS and its components
from childhood to adolescence, due a mean of 6.6 years
of followup for the ﬁrst time in Middle East region using
general estimation equation (GEE) analysis.
2.MaterialsandMethods
Subjects in this study were selected from among participants
of the Tehran Lipid and Glucose Study (TLGS), a prospective
study conducted to determine the risk factors and outcomes
for noncommunicable diseases [23]. To summarize, 15,005
people, aged 3 years and over, residents of district-13 of
Tehran underwent a baseline examination between February
1999 and August 2001. After this cross-sectional (phase 1),
subjects were categorized into the cohort and intervention
groups, the latter to be educated for implementation of life-
style modiﬁcations. We used metabolic and anthropometric
data from phases I (1999–2001), II (2002–2005), and III
(2006–2008) of the TLGS. For the current study, 5439
participants, 2643 boys and 2797 girls, aged 6–18 years
who had participated at least in one of three phases, were
enrolled. The study was approved by the institutional ethics
committee of the Research Institute for Endocrine Sciences,
aﬃliated to Shahid Beheshti University of Medical Sciences
and was conducted in accordance with the principles of the
Declaration of Helsinki.
Details of the TLGS protocol and all laboratory proce-
dures have been published elsewhere [10]. Brieﬂy, trained
interviewers collected information, using a pretested ques-
tionnaire which included demographic data and anthro-
pometric indices. Weight, height, and waist circumference
(WC) were measured using standard protocols. Body mass
index (BMI) was calculated as weight in kilograms, divided
by height in meters squared. A qualiﬁed physician measured
blood pressure twice with the subject in a seated position
after one initial measurement for determining peak inﬂation
level using a standard mercury sphygmomanometer; the
mean of two measurements was considered to be the
participant’s blood pressure. Fasting blood samples for
the measurement of glucose and lipid concentrations were
drawn after the subjects had fasted overnight. Fasting blood
glucose (FBG) was measured on the day of blood collec-
tion by the enzymatic colorimetric method using glucose
oxidase. Triglyceride (TG) concentrations were measured by
commercially available enzymatic reagents (Pars Azmoon,
Tehran, Iran) adapted to a Selectra autoanalyzer. High-
density lipoprotein cholesterol (HDL-C) was measured after
precipitation of the apolipoprotein B-containing lipopro-
teins with phosphotungstic acid.
2.1. Deﬁnitions. We used the deﬁnition based on Cook et al.
work for deﬁnition of the MetS in children and adolescents
[24]. This deﬁnition is based on criteria analogous to that
of the National Cholesterol Education Program Expert Panel
on Detection, Evaluation and Treatment of High Blood
Cholesterol in Adult Treatment Panel III [1]; it deﬁnes MetS
as three or more of the following: fasting TG ≥ 110mg/dL;
HDL cholesterol <40mg/dL; WC ≥ 90th percentile for age
and sex, according to national reference curves [25]; systolic
blood pressure (SBP) and/or diastolic blood pressure (DBP)
≥90th percentile for sex, age and height, from national
reference cut-oﬀ points [26]; FBG ≥ 100mg/dL. For the
subjects who were aged over 18 years after the followup,
we used the criteria for MetS in adults, speciﬁed by the
JointInterimStatement(JIS)[27].Obesitywasdeﬁnedbased
on the standardized percentile curves of BMI suggested for
Iranian children and adolescents as ≥95th percentile of BMI
for age and sex [6].
2.2. Statistic Analysis. All continuous data are expressed
as mean ± SD, and categorical variables are expressed as
percentages. Independent t-test was used to compare diﬀer-
ence between two sexes within in each phase. The general
estimation equation (GEE) use the generalized linear model
to estimate more eﬃcient and unbiased analysis of demo-
graphic variables, anthropometric indices, and biochemical
variables collected in longitudinal, nested, or repeated mea-
sures designs [28, 29]. This method relies on independence
across subjects to consistently estimate the variance of
the proposed estimators even when the assumed working
correlation structure is incorrect. Logistic regression analysis
was performed using GEE method for binominal variables.
Variables were adjusted for age (years), time (phase) and
intervention.
All analyses were performed using SPSS for Windows
(version 16; SPSS Inc., Chicago, IL, USA), and signiﬁcance
was set at P<0.05.
3. Results
For the current study, we had 3,854, 3,057, and 3,441
observations in phases I, II, and III, respectively. The GEE
analysiswasperformedwith5,439subjects(2643boys),aged
6–18 years, who had at least one observation in whole period
the study. At baseline, girls had higher mean values for WC
(P = 0.04), TG (P = 0.01), LDL, and cholesterol (P<0.001)
but lower SBP and FBS than boys (P<0.001). At the end
of followup, all factors were higher in boys, while cholesterol
and HDL values were higher in girls (P = 0.001, Table 1).
The crude prevalence of obesity increased in both sexes
during a median follow-up of 6.6 years. Abdominal obesity
increased from 12.3% to 33.1 in phase III in boys, but
remained fairly stable in girls. The most frequent component
of MetS was low HDL at baseline (39%) that increased up to
47% for boys and 43% for girls in the third phase. High TG
was the next most prevalent component that decreased from
35% and 31% at baseline to 21% and 25% in girls and boys,
respectively. The prevalence of MetS was 13.2% for boys at
baseline that increased to 16.4% in the third phase. In girls,
the prevalence of Mets decreased from 11.8% at baseline to
6% during followup (Figure 1).Cholesterol 3
Table 1: Anthropometric and metabolic characteristics of cohort participants by sex in 3 phases.
Phase I Phase II Phase III
Boys
N = 1858
Girls
N = 1995
Boys
N = 1415
Girls
N = 1641
Boys
N = 1592
Girls
N = 1849
Age (year) 12.5 ±3.51 2 .6 ±3.61 4 .2 ±4.53 14.7 ±4.51 6 .0 ±5.61 6 .6 ±5.4
Weight (kg) 44.7 ±19.24 2 .7 ± 15.56∗ 53.1 ±21.84 8 .2 ±16.0∗ 59.3 ±23.65 1 .4 ± 15.7∗
BMI (kg/m2)1 8 .9 ±4.41 9 .0 ±4.52 0 .6 ±5.02 0 .6 ±4.52 2 .0 ±6.32 1 .4 ±4.6∗
Overweight (%) 19.7 17.5 28.3 23.7∗ 34.3 27.2∗
Obesity (%) 8.3 6∗ 11.9 8.4∗ 13.8 8.9∗
WC (cm) 65.0 ±12.56 5 .7 ±10.8∗ 73.6 ±14.66 9 .0 ±11.3∗ 77.8 ±15.86 9 .2 ± 11.0∗
Abdominal obesity (%) 12.3 13.7 26.9 14.3∗ 33.1 13∗
SBP (mmHg) 106.2 ±12.2 103.6 ±11.3∗ 104.0 ±13.09 8 .8 ±11.3∗ 104.6 ±13.29 8 .3 ± 11.3∗
DBP (mmHg) 71.1 ±9.57 1 .2 ±9.46 7 .2 ±10.06 7 .2 ±9.46 7 .5 ±10.56 4 .7 ±9.6∗
FBG (mg/dL) 88.9 ±11.38 6 .9 ±8.3∗ 88.7 ±11.68 6 .2 ±7.4∗ 86.9 ±7.58 4 .7 ±7.0∗
TG (mg/dL) 103.7 ±60. 7 107.9 ±54.9∗ 101.6 ±54.49 9 .0 ±47.7 105.2 ±61.49 4 .6 ± 45.9∗
HDL-C (mg/dL) 44.0 ±10.84 4 .0 ±10.54 0 .8 ±10.34 1 .5 ±10.14 2 .8 ±10.34 5 .6 ± 10.4∗
Data are presented as mean (SD) or percent.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, triglycerides
HDL-C, high density lipoprotein cholesterol. Overweight deﬁned as ≥85th to <95th percentile of BMI for age and sex; obesity deﬁned as ≥95th percentile of
BMI for age and sex; abdominal obesity deﬁned as WC ≥ 90th percentile for age and sex.
∗P<0.001 (between boys and girls in each phase).
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Figure 1: Prevalence of metabolic syndrome (MetS) and its components in boys (n = 2643) and girls (n = 2797). Obesity deﬁned as ≥95th
percentile of BMI for age and sex; high waist circumference (H-WC) ≥90th percentile for age and sex, according to national reference curves;
high blood pressure (H-BP), SBP and/or DBP ≥90th percentile for sex, age and height, from national reference cut-oﬀ points; high fasting
blood glucose (H-FBG), fasting glucose ≥100mg/dL; high triglycerides (H-TG), fasting TG ≥ 110mg/dL; low HDL cholesterol (L-HDL),
HDL < 40mg/dL.
The odds of obesity over the whole study period were
raised in both sexes (P<0.01). While the odds of abdominal
obesity increased signiﬁcantly in boys (P<0.001), whereas
no signiﬁcant change was observed in girls (P = NS). The
odds for all other MetS component values declined towards
the end of followup, except for HDL in girls. At three time
points, the odds of MetS decreased signiﬁcantly in girls (OR:
0.69 and 0.55 P<0.001 in phases II and III, resp.) but no
signiﬁcant diﬀerence was observed in boys (OR: 1.1 and 0.94
P = NS in phases II and III resp., Table 2).
4. Discussion
UsingGEEanalysis,theresultsofpresentstudyconductedon
5,439 Tehranian children and adolescents, aged 6–18 years,
suggestthatduringamedianfollow-upof6.6years,thetrend
of obesity increased in both sexes and for abdominal obesity
increasedalmostthreefoldsinboys.Inspiteoftheincreasing
trend for the above factors, the trend for MetS decreased in
girls and remained relatively stable in boys.
The high prevalence of obesity and MetS in childhood
and adolescence has been shown to increase the prevalence4 Cholesterol
Table 2: Odd ratiosa of the incident MetS parameters in phase I, II and III.
Characteristics phase I phase II phase III
Boys
obesity 1 1.40 (1.16–1.68)∗ 1.49 (1.19–1.87)∗
Abdominal obesity 1 2.28 (1.95–2.67)∗ 2.61 (2.19–3.12)∗
High FBG 1 0.90 (0.69–1.18) 0.47 (0.34–0.64)∗
Low HDL-C 1 1.51 (1.32–1.73)∗ 0.84 (0.73–0.96)∗
High TG 1 0.68 (0.58–0.78)∗ 0.63 (0.54–0.74)∗
High BP 1 0.45 (0.37–0.53)∗ 0.42 (0.34–0.52)∗
MetS 1 1.1 (0.90–1.33) 0.94 (0.73–1.22)
Girls
obesity 1 1.42 (1.14–1.77)∗ 1.41 (1.07–1.84)∗
Abdominal obesity 1 1.08 (0.912–1.28) 0.98 (0.79–1.21)
High FBG 1 0.78 (0.56–1.08) 0.59 (0.42–0.83)∗
Low HDL-C 1 1.89 (1.66–2.14)∗ 1.07 (0.93–1.22)
High TG 1 0.65 (0.67–0.75)∗ 0.50 (0.43–0.58)∗
High BP 1 0.50 (0.43–0.58)∗ 0.21 (0.16–0.27)∗
MetS 1 0.21 (0.16–0.27)∗ 0.55 (0.41–0.75)∗
Obesity, BMI ≥ 95th percentile for age and sex; abdominal obesity, WC ≥ 90th percentile for age and sex; high FBG, FBS ≥ 100 (mg/dL); Low HDL-C, HDL-
C < 40 (mg/dL); high TG, TG ≥ 110 (mg/dL); High BP, SBP, and/or DBP ≥90th percentile for sex, age, and height.
a(95% Conﬁdence interval).
∗P value <0.05 compare to phase I.
of cardiovascular events in adults [30]. Childhood and
adolescent MetS have evolved into a worldwide epidemic,
up to 14% in Australian [31] and 11% in Italian children
[32]. Findings from previous studies in Iran have revealed
a higher prevalence of MetS among Iranian children (9.8%
[7]) compared with western (4.2% in US [24]) and Asian
countries (1.4% in Japan [33] and 1.8% in Korea [15]6 . 6 %
in China [34]). Several previous epidemiological studies
demonstrated diﬀerent trends for MetS and cardiometabolic
risk factors among children and adolescents [13–17], which
can be explained by variety in MetS deﬁnitions, length of
followup, and also speciﬁc cultural and ethnical composition
of studied population, lifestyle, and public health policies.
In the Young Finns Study, a follow-up study of 1769 girls
and 1688 boys, aged 3–18 years old, the prevalence of
MetS increased with age in boys, and in 9–12 years old
age girls [17]. The results from the Quebec family study
indicated that indicators of MetS are moderately stable from
childhoodtoadolescence[16].BasedontheFelslongitudinal
study, authors concluded that 8 cardiometabolic risk factors
associated with the MetS were relatively stable among
children and adolescents [13]. On the other hand, results
from the Korean NHANES Survey on 4164 subjects, aged
10–19 years, demonstrated a decline in prevalence of MetS,
despite an increase in obesity in Korean adolescents [15]. In
agreement with the Korean study, despite increasing trend of
obesity, we found a decreasing trend of MetS in girls, but it
relatively stable in boys mostly as a result of improvement in
other MetS components. Similarly, an increasing prevalence
of childhood obesity has been reported around the world
[35–37]. Rapidly changing dietary practices and a sedentary
lifestyle have led to increasing prevalence of childhood obe-
sity (5–19 years) in developing countries recently [38]s u c h
as Iran [22]. Moreover, recent systematic reviews and meta-
analyses of available randomized trials reported nonsignif-
icant eﬀects of pharmacologic and behavioral treatments
for reduction of overweight and obesity in children and
adolescents [39, 40]. Regarding above mentioned studies,
cardiometabolic risk factors were stable across time besides
increasing trend of obesity in children and adolescents.
Thedecreasingprevalenceofcardiometabolicriskfactors
can be explained by the positive eﬀects of public health
interventions in terms of lifestyle behaviors and increased
physical activity on unfavorable risk factors. Accordingly, a
systematic reviewhas shown thathigher physical activity lev-
els were consistently associated with an improved metabolic
proﬁle and a reduced risk for MetS and/or insulin resistance
in pediatric populations [41]. We speculate that recent
changes in physical activity in addition to national health
care initiatives in Tehran may have had a positive impact
on the prevalence of MetS. We also found some notable
diﬀerences between genders in the trend of MetS, for which
however we do not have an adequate explanation; it could
possibly be explained by more focus of public educational
programs on girls compared to boys, leading to decreasing
t r e n do fM e t Si ng i r l s .
The strength of our study was the considerable sample
size of children and adolescents with a long followup period
over which we measured MetS and its components enabling
us to assess the time eﬀect of these risk factors in our
population using the GEE model for the ﬁrst time.
However, our study had several limitations. First, our
subjects were from a homogeneous population, potentially
limiting the generalizability of our results. Second, we did
not have data regarding puberty status which have helped
us to assess the eﬀects of puberty on MetS, and third, weCholesterol 5
did not take into account some possible confounders such
as physical activity, dietary habits, and socioeconomic status
in our analysis.
5. Conclusion
In conclusion, inspite of the increasing trend for obesity
in both sexes, the trend for MetS decreased in girls and
remained relatively stable in boys in our population. Given
the proven association between childhood and adolescence,
obesity, and accuracy of cardiovascular events in adulthood,
we are not sure that our observations, indicating persistency
ofexcessweightalongwithreductionofcardiometabolicrisk
factors can be translated to decrease cardiovascular event
rates in future adulthood. Further prospective studies with
long-term followup are needed to answer this question.
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